Literature DB >> 17632536

The pharmaceutical industry at risk: how excessive government regulation stifles innovation.

R A Epstein1.   

Abstract

In the fall of 2006, I published a book, Overdose: How Excessive Government Regulation Stifles Pharmaceutical Innovation. The book goes against the conventional wisdom found in the academic and popular literature on the topic by offering a more sympathetic view of the pharmaceutical industry.

Entities:  

Mesh:

Year:  2007        PMID: 17632536     DOI: 10.1038/sj.clpt.6100257

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  2 in total

1.  Effect of safety issues with HIV drugs on the approval process of other drugs in the same class: an analysis of European Public Assessment Reports.

Authors:  Arna H Arnardottir; Flora M Haaijer-Ruskamp; Sabine M J Straus; Pieter A de Graeff; Peter G M Mol
Journal:  Drug Saf       Date:  2011-11-01       Impact factor: 5.606

2.  Additional safety risk to exceptionally approved drugs in Europe?

Authors:  Arna H Arnardottir; Flora M Haaijer-Ruskamp; Sabine M J Straus; Hans-Georg Eichler; Pieter A de Graeff; Peter G M Mol
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.